Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer

By Dragutinović Vesna   Radonjić Nevena   Petronijević Nataša   Tatić Svetislav   Dimitrijević Ivan   Radovanović Nebojša   Krivokapić Zoran  

Molecular and Cellular Biochemistry, Vol. 355, Iss. 1-2, 2011-09 ,pp. : 173-178

Springer Publishing Company

Access to resources Recommend Favorite

Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers

By Luizon Marcelo Rizzatti   de Almeida Belo Vanessa  

Biomarkers, Vol. 17, Iss. 3, 2012-05 ,pp. : 286-288

Informa Healthcare

Access to resources Recommend Favorite

Prognostic value of transforming growth factor beta 1 [TGF-β1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma

By Elahi Maryam   Rakhshan Vahid   Ghasemian Nasim Taghavi   Moshref Mohamad  

Biomarkers, Vol. 17, Iss. 1, 2012-02 ,pp. : 21-27

Informa Healthcare

Access to resources Recommend Favorite

Low serum MMP-1 in breast cancer: a negative prognostic factor?

By Kulić A.   Dedić Plavetić N.   Vrbanec J.   Sirotković-Skerlev M.  

Biomarkers, Vol. 17, Iss. 5, 2012-08 ,pp. : 416-421

Informa Healthcare

Access to resources Recommend Favorite

Regulation of ProMMP-1 and ProMMP-3 Activation by Tissue Factor Pathway Inhibitor-2/Matrix-Associated Serine Protease Inhibitor

By Rao C.N.   Mohanam S.   Puppala A.   Rao J.S.  

Biochemical and Biophysical Research Communications, Vol. 255, Iss. 1, 1999-02 ,pp. : 94-98

Elsevier

Access to resources Recommend Favorite